These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6156644)

  • 1. Mode of action of a new nalidixic acid derivative, AB206.
    Nagate T; Komatsu T; Izawa A; Ohmura S; Namiki S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 May; 17(5):763-9. PubMed ID: 6156644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activity of AB206, a new naphthyridine derivative.
    Nagate T; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):203-8. PubMed ID: 7387143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of miloxacin.
    Izawa A; Kisaki Y; Irie K; Eda Y; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1980 Jul; 18(1):37-40. PubMed ID: 7416749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalidixic acid: an antibacterial paradox.
    Crumplin GC; Smith JT
    Antimicrob Agents Chemother; 1975 Sep; 8(3):251-61. PubMed ID: 1101818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.
    Stevens PJ
    J Antimicrob Chemother; 1980 Jul; 6(4):535-42. PubMed ID: 6159344
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and experimental study of dioxidine. Its antibacterial action].
    Bekbergenov BM; Antipov AV; Danil'iants EV; Korolev PN; Glezer GA
    Antibiotiki; 1982 May; 27(5):349-52. PubMed ID: 6179463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality.
    Deitz WH; Cook TM; Goss WA
    J Bacteriol; 1966 Feb; 91(2):768-73. PubMed ID: 5327367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyclic and tricyclic analogs of quinolones: mechanism of action.
    Georgopapadakou NH; Dix BA; Angehrn P; Wick A; Olson GL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):614-6. PubMed ID: 3037999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical effects of oxolinic acid on Proteus vulgaris.
    Pianotti RS; Mohan RR; Schwartz BS
    J Bacteriol; 1968 May; 95(5):1622-6. PubMed ID: 5650072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS.
    GOSS WA; DEITZ WH; COOK TM
    J Bacteriol; 1965 Apr; 89(4):1068-74. PubMed ID: 14276097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross resistance of quinolone derivatives in gram-negative bacteria.
    Barba D; Pennucci C; Esposito S; Galante D
    Chemioterapia; 1985 Apr; 4(2):192-6. PubMed ID: 3159488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
    Jpn J Antibiot; 1981 Sep; 34(9):1335-52. PubMed ID: 7328756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature of the penetration barrier in Escherichia coli K-12: effect of macromolecular inhibition of penetrability in strains containing the envA gene.
    Normark S; Westling B
    J Bacteriol; 1971 Oct; 108(1):45-50. PubMed ID: 4941566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial nitroacridine, Nitroakridin 3582: effects on bacterial growth and macromolecular biosynthesis in vivo.
    Wolfe AD; Cook TM; Hahn FE
    J Bacteriol; 1971 Oct; 108(1):320-7. PubMed ID: 4941562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
    Gellert M; Mizuuchi K; O'Dea MH; Itoh T; Tomizawa JI
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4772-6. PubMed ID: 337300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.